An Italian Multicentric Retrospective Observational Study to Assess Effectiveness and Safety of the Combination of Tafasitamab and Lenalidomide in Diffuse Large B-cell Lymphoma Patients Treated Under Named Patient Program
Recruiting now
Conditions studied: Diffuse Large B Cell Lymphoma (DLBCL)
In brief
The study is pilot, observational, retrospective, Italian multicenter study.
Key facts
- Study ID
- NCT06782789
- Run by
- IRCCS Azienda Ospedaliero-Universitaria di Bologna
- People needed
- 96
- Starts
- 2024-03-01
- Expected to finish
- 2026-08-01
- Last updated by the study team
- 2025-01-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Histologically confirmed diagnosis of R/R DLBCL.
- Patientswho received at least one dose of tafasitamab in association with lenalidomide under the NPP (D.M. 7 Sep 2017), between April 2022 and December 2022.
- Age ≥ 18 years at enrollment.
- Signature of written informed consent (if applicable).
You may not qualify if…
- R/R DLBCL patients who received tafasitamab in association with lenalidomide in a clinical trial context.
Where it is running
- IRCCS Azienda Ospedaliero - Universitaria di Bologna — Bologna, Bologna, Italy (enrolling)
- AO Sant'Anna e San Sebastiano di Caserta — Caserta, Caserta, Italy (enrolling)
- A.R.N.A.S. Garibaldi — Catania, Catania, Italy (enrolling)
- Azienda Ospedaliera Universitaria Arcispedale S. Anna — Ferrara, Italy (enrolling)
- Azienda Ospedaliero Universitaria Careggi — Florence, Italy (enrolling)
- Irccs Ospedale San Raffaele — Milan, Italy (enrolling)
- Azienda Ospedaliero-Universitaria Maggiore della Carità — Novara, Italy (enrolling)
- Azienda Ospedaliera Villa Sofia Cervello — Palermo, Italy (enrolling)
- Ospedale Guglielmo da Saliceto di Piacenza — Piacenza, Italy (enrolling)
- IRCCS- Istituto Nazionale Tumori Regina Elena — Roma, Italy (enrolling)
- Fondazione Policlinico Universitario A. Gemelli IRCCS — Roma, Italy (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.